Sellas Life Sciences Group Inc. SLS, -53.25% said Friday that it raised $20.0 million, through the public sale of common shares and warrants to buy stock. Shares of the biopharmaceutical company, whic...
Tag: IBB
Cingulate stock skyrockets after ADHD treatment shows positive trial results
Shares of Cingulate Inc. CING, +51.30% skyrocketed 82.9% toward an 11-month high in active premarket trading Friday, after the biopharmaceutical company reported positive results from a trial of its a...
Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment
Shares of Kala Pharmaceuticals Inc. KALA, +60.35% have rocketed higher in for three-straight sessions, toward a more-than 8-fold gain, since the biopharmaceutical company announced positive news regar...
Kala Pharmaceuticals stock rockets nearly 300% after FDA OKs IND application for PCED treatment
Shares of Kala Pharmaceuticals Inc. KALA, +219.90% quadrupled in very volatile trading Wednesday, after the biopharmaceutical company said the Food and Drug Administration accepted its investigational...
Rigel stock soars after FDA approves leukemia treatment, 2 days after receiving delisting notice
Shares of Rigel Pharmaceuticals Inc. RIGL, +1.86% soared 39.5% in premarket trading Friday, after the biotechnology company announced Food and Drug Administration approval of its Rezlidhia leukemia tr...
Ardelyx stock rockets on heavy volume after positive FDA panel vote on kidney disease treatment
Shares of Ardelyx Inc. ARDX, +35.66% rocketed 75.4% on heavy volume toward a 16-month high in premarket trading Thursday, after an advisory panel of the U.S. Food and Drug Administration voted that be...
Applied DNA stock surges again, for 4-day gain of more than 870%
Shares of Applied DNA Sciences Inc. APDN, +1.57% jumped another 15.2% in morning trading Friday, to snap back from an earlier intraday loss of as much as 8.7%. The biotechnology company’s stock ...
Applied DNA Sciences pulls back after 6-fold surge in 2 days, after ‘upsized’ equity offering prices
Shares of Applied DNA Sciences Inc. APDN, +40.00% pulled back 5.1% in morning trading Thursday, after the biotechnology company announced the pricing of its “upsized” public equity offerin...
Applied DNA stock soars more than 80% active trading, after quadrupling in the previous session
Shares of Applied DNA Sciences Inc. APDN, +46.30% shot up 84.0% in premarket trading, after they more than quadrupled in the previous session (up 311.2%) in the wake of the biotechnology company’...
Applied DNA Sciences blasts more than 350% higher after initiating validation of monkeypox virus test
Shares of Applied DNA Sciences Inc. APDN, +311.16% skyrocketed 353.7% higher in very volatile trading Tuesday, after the biotechnology company said it initiated validation of a monkeypox virus test. T...
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
If you want to know how much investors hate the biotech sector right now, consider this simple statistic: More than 25% of small biotech companies have stock-market capitalizations that are smaller th...
Veru’s stock nearly triples after oral COVID-19 treatment leads to ‘statistically meaningful’ reduction in deaths
Shares of Veru Inc. VERU, +182.30% rocketed 175% toward a 13-month high in afternoon trading Monday, after biopharmaceutical company announced positive results from its Phase 3 trial of its oral COVID...
Get ready for the climb. Here’s what history says about stock-market returns during Fed rate-hike cycles.
Bond yields are rising again so far in 2022. The U.S. stock market seems vulnerable to a bona fide correction. But what can you really tell from a mere two weeks into a new year? Not much and quite a ...
Immuron stock rockets after funding by U.S. DoD of new research agreement
Shares of Immuron Ltd. IMRN, +2.67% rocketed 49.6% in active premarket trading Wednesday, after the Australia-based biopharmaceutical company said it received an award of AUD$6.2 million ($4.5 million...
Biotech Stocks Are Due to Bounce Back. This One Stands Out.
Text size Large-cap biotech will offer a smoother ride than small, and Vertex, in particular, looks attractive. Igor Akimov/Dreamstime.com Biotech stocks began the year in much the same way they ended...
Genprex stock more than doubles on very heavy volume after FTD granted for cancer treatment
Shares of Genprex Inc. GNPX, +167.18% skyrocketed 121% on massive volume in afternoon trading Monday, after the gene therapy company said its Reqorsa Immunogene Therapy was granted Fast Track Designat...
Immix Biopharma’s stock rockets after pediatric cancer treatment granted RPD by the FDA
Shares of Immix Biopharma Inc. IMMX, +9.20% rocketed 66.0% in premarket trading Monday, after the biopharmaceutical company said its IMX-110 was granted Rare Pediatric Disease (RPD) designation by the...
Fate Therapeutics stocks heads for record selloff after Janssen collaboration terminated and job cuts
Shares of Fate Therapeutics Inc. FATE, -61.18% plunged 56.8% in premarket trading, putting them on track for a record one-day selloff, after the biopharmaceutical company announced the termination of ...